Product Surveillance Registry

ConditionsCardiac Rhythm Disorders Urological Disorders Neurological Disorders Cardiovascular Disorders Digestive Disorders Intracranial Aneurysm Mechanical Circulatory Support Respiratory Therapy Aortic, Peripheral Vascular and Venous Disorders Minimally Invasive Surgical Procedures Diagnostic Techniques and Procedures Surgical Procedures, Operative Renal Insufficiency Neurovascular Coronary Artery Disease Ear, Nose and Throat Disorder

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

AgeNot listed

SponsorMedtronic

About this trial

The purpose of the Registry is to provide continuing evaluation and periodic reporting of safety and effectiveness of Medtronic market-released products. The Registry data is intended to benefit and support interests of patients, hospitals, clinicians, regulatory bodies, payers, and industry by streamlining the clinical surveillance process and facilitating leading edge performance assessment via the least burdensome approach.

Eligibility criteria

Qualifiers

Patient or legally authorized representative provides written authorization and/or consent per institution and geographical requirements

Patient has or is intended to receive or be treated with an eligible Medtronic product

Patient within enrollment window relative to therapy initiation or meets criteria for retrospective enrollment

Disqualifiers

Patient who is, or will be, inaccessible for follow-up

Patient with exclusion criteria required by local law

Patient is currently enrolled in or plans to enroll in any concurrent drug and/or device study that may confound results

Trial design

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Locations

395

Argentina

Buenos Aires Argentina

Australia

WestmeadNew South Wales, Australia

Chermside Australia

Murdoch Australia

Sponsors and collaborators

Medtronic

Lead sponsor

Source ClinicalTrials.gov